The authors describe the latest advances in cell therapy, biomaterials and 3D bioprinting for the treatment of cardiovascular disease.
[Current Opinion in Cardiology]
6445212 SPSX8DXS items 1 apa 0 default asc 1 166215 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-5144f2ef1d870e6f939a788c6c8b4c57%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22SPSX8DXS%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sedlakova%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-26%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESedlakova%2C%20V.%2C%20Ahumada%2C%20M.%2C%20Suuronen%2C%20E.%20J.%2C%20%26amp%3B%20Alarcon%2C%20E.%20I.%20%282021%29.%20Building%20new%20cardiac%20vasculature%20and%20myocardium%3A%20where%20are%20we%20at%3F%20%3Ci%3ECurrent%20Opinion%20in%20Cardiology%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FHCO.0000000000000905%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FHCO.0000000000000905%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DSPSX8DXS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Building%20new%20cardiac%20vasculature%20and%20myocardium%3A%20where%20are%20we%20at%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronika%22%2C%22lastName%22%3A%22Sedlakova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%22%2C%22lastName%22%3A%22Ahumada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20J.%22%2C%22lastName%22%3A%22Suuronen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilio%20I.%22%2C%22lastName%22%3A%22Alarcon%22%7D%5D%2C%22abstractNote%22%3A%22Purpose%20of%20review%5Cu00a0%5Cn%20%20%20%20%20%20%20%20This%20review%20describes%20the%20latest%20advances%20in%20cell%20therapy%2C%20biomaterials%20and%203D%20bioprinting%20for%20the%20treatment%20of%20cardiovascular%20disease.%5Cn%20%20%20%20%20%20%20%20Recent%20findings%5Cu00a0%5Cn%20%20%20%20%20%20%20%20Cell%20therapies%20offer%20the%20greatest%20benefit%20for%20patients%20suffering%20from%20chronic%20ischemic%20and%20nonischemic%20cardiomyopathy.%20Rather%20than%20replacing%20lost%20cardiomyocytes%2C%20the%20effects%20of%20most%20cell%20therapies%20are%20mediated%20by%20paracrine%20signalling%2C%20mainly%20through%20the%20induction%20of%20angiogenesis%20and%20immunomodulation.%20Cell%20preconditioning%2C%20or%20genetic%20modifications%20are%20being%20studied%20to%20improve%20the%20outcomes.%20Biomaterials%20offer%20stand-alone%20benefits%20such%20as%20bioactive%20cues%20for%20cell%20survival%2C%20proliferation%20and%20differentiation%2C%20induction%20of%20vascularization%20or%20prevention%20of%20further%20cardiomyocyte%20death.%20They%20also%20provide%20mechanical%20support%20or%20electroconductivity%2C%20and%20can%20be%20used%20to%20deliver%20cells%2C%20growth%20factors%20or%20drugs%20to%20the%20injured%20site.%20Apart%20from%20classical%20biomaterial%20manufacturing%20techniques%2C%203D%20bioprinting%20offers%20greater%20spatial%20control%20over%20biomaterial%20deposition%20and%20higher%20resolution%20of%20the%20details%2C%20including%20hollow%20vessel-like%20structures.%5Cn%20%20%20%20%20%20%20%20Summary%5Cu00a0%5Cn%20%20%20%20%20%20%20%20Cell%20therapy%20induces%20mainly%20angiogenesis%20and%20immunomodulation.%20The%20ability%20to%20induce%20direct%20cardiomyocyte%20regeneration%20to%20replace%20the%20lost%20cardiomyocytes%20is%2C%20however%2C%20still%20missing%20until%20embryonic%20or%20induced%20pluripotent%20stem%20cell%20use%20becomes%20available.%20Cell%20therapy%20would%20benefit%20from%20combinatorial%20use%20with%20biomaterials%2C%20as%20these%20can%20prolong%20cell%20retention%20and%20survival%2C%20offer%20additional%20mechanical%20support%20and%20provide%20inherent%20bioactive%20cues.%20Biomaterials%20can%20also%20be%20used%20to%20deliver%20growth%20factors%2C%20drugs%2C%20and%20other%20molecules.%203D%20bioprinting%20is%20a%20high-resolution%20technique%20that%20has%20great%20potential%20in%20cardiac%20therapy.%22%2C%22date%22%3A%22August%2026%2C%202021%22%2C%22language%22%3A%22en-US%22%2C%22DOI%22%3A%2210.1097%5C%2FHCO.0000000000000905%22%2C%22ISSN%22%3A%220268-4705%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.lww.com%5C%2Fco-cardiology%5C%2FAbstract%5C%2F9000%5C%2FBuilding_new_cardiac_vasculature_and_myocardium_.98868.aspx%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-30T17%3A46%3A55Z%22%7D%7D%5D%7D
Sedlakova, V., Ahumada, M., Suuronen, E. J., & Alarcon, E. I. (2021). Building new cardiac vasculature and myocardium: where are we at? Current Opinion in Cardiology. https://doi.org/10.1097/HCO.0000000000000905 Cite